Market research
B8F.F Biofrontera AG
F EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 984K
- P/E ratio
- Not available
- Analyst target
- 5.55
- Dividend yield
- Not available
- Beta
- 0.64
Community
Investor discussion
1 comment
Sign in to join the B8F.F discussion.
5 years, 5 months ago
Biofrontera AG is currently in a long term downtrend where the price is trading 2.8% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.3.
Biofrontera AG's total revenue sank by 8.6% to $5M since the same quarter in the previous year.
Its net income has increased by 53.5% to $-5M since the same quarter in the previous year.
Based on the above factors, Biofrontera AG gets an overall score of 2/5.